TRANXENE

Medicinal product

(Invented) name

TRANXENE

Active substance (s)

Dikalio klorazepatas monohidratas

Strength

5 mg

Pharmaceutical form

kietosios kapsulės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N05BA05, Potassium clorazepate

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-04-25

Date of renewal

Documents

2522_TRANXENET_5mg_k_kaps_N30_PZ.docx

2522_2523_TRANXENET_5mg_10mg_k_kaps_N30_PIL.docx

Stage

Registruotas

Controlled?

Yes

Controlled substance type

Psichotropinis

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Kapsulėje yra:	1 vnt.
Dikalio klorazepatas monohidratas	5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117415	103520	1103520	lizdinė plokštelė	N30		Receptinis	LT/L/25/2522/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-04-25	Registruotas